HIGHLIGHTS   |  November 7, 2019   FDA Approves Third Pegfilgrastim Biosimilar, LA-EP2006 The FDA approved a biosimilar to pegfilgrastim, called LA-EP2006, to decrease the incidence of infection, exhibited from febrile neutropenia. Read more     Danish Team Discovers Possible Cancer Culprit: ‘Protein Scaffolding’ for DNA Repair A relatively enormous 'protein scaffolding' network that stabilizes and then fixes DNA damage was found to be a potential cause of cancer by a team of scientists in Denmark if the mechanism utilizing the proteins 53BP1 and RIF1 malfunction. Read more IN CASE YOU MISSED IT   ICYMI: Analysis of Cervical Mutations Aids Endometrial Cancer Diagnosis A study published in the International Journal of Cancer showed that analyzing mutations either from cervical cytology or from pipelle endometrial biopsies increases the chance of catching endometrial carcinoma earlier. Read more